QP 26 - Bio 7: Radiation Cancer Biology and Immune Response

Moderator(s)

• 

  Everett Moding, MD, PhD

  Stanford University
  Stanford, CA
• 

  Ariel Marciscano, MD

  Massachusetts General Hospital
  Boston, Massachusetts, United States

Presentations:

• 12:30 PM – 12:35 PM ET

  Introduction
• 12:35 PM – 12:40 PM ET

  Immunological effectiveness of carbon ion radiotherapy in pancreatic cancer
  

  Presenter: Brett Bell, MS – Albert Einstein College of Medicine
• 12:40 PM – 12:45 PM ET

  Investigating the Roles of the Epithelial-Mesenchymal Transition Program in Small Cell Lung Cancer Tumorigenesis and Chemoradiation Response
  

  Presenter: Triet Nguyen, BA – Johns Hopkins Medicine
• 12:45 PM – 12:50 PM ET

  Oral Bifidobacterium Longum BL21 Supplements in the Prevention of Acute Radiation-induced Intestinal Injury: A Single-Arm, Phase 2 Trial
  

  Presenter: Ruiqiu Zhu, MD, PhD – Soochow University
• 12:50 PM – 12:55 PM ET

  Radiotherapy-Induced Tumor Cell Senescence Reprograms Anti-Tumor Immunity in a p21 Dependent Manner
  

  Presenter: Zengfu Zhang, MD – Shandong Cancer Hospital and Institute
• 12:55 PM – 1:00 PM ET

  Molecular Mechanisms Underlying Liver Metastasis in Hypofractionated Radiotherapy-Resistant Colorectal Cancer
  

  Presenter: Weitao Wen, PhD – Shandong Cancer Hospital Affiliated to Shandong First Medical University
• 1:00 PM – 1:05 PM ET

  A Lymph Node Immune Score (LNIS) Identifies Prognostic Immune Phenotypes Shared across Head and Neck Cancers
  

  Presenter: Michael Spiotto, MD, PhD – The University of Texas MD Anderson Cancer Center
• 1:05 PM – 1:25 PM ET

  Questions and Answers
• 1:25 PM – 1:30 PM ET

  Closing